Tyra Biosciences, Inc.
Yuliya Rueb (Vice President, Finance (PAO)) reports TYRA insider transactions
About this filing
Tyra Biosciences, Inc. (TYRA) filed Form 4 (insider transaction) with the SEC on Sep 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Yuliya Rueb · Vice President, Finance (PAO)
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | A · grantFootnotes F1, F2, F3 | +2,925 | $9.13 | $26,702.32 | 11,258 | Direct |
Footnotes
- F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- F2 Includes restricted stock units.
- F3 The previously filed Form 4 overstated the number of securities beneficially owned by the Reporting Person in column 5, due to a clerical error, which has been corrected on this Form 4.
More TYRA filings
- SC 13G/A
Filed Oct 27, 2026
- SC 13G
Filed Sep 21, 2026
- 4
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
- SC 13D/A
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.